Resultados de la búsqueda

6 items
  1. Fixing a broken system

    • Juan Carlos Garzón Vergara
    30 Diciembre 2014
    Report

    Despite efforts by governments in Latin America, illicit drugs continue to provide one of the largest incomes for criminal organizations, enabling them to penetrate and corrupt political and social institutions.

  2. The International Drug Control Regime and Access to Controlled Medicines

    • Christopher Hallam
    28 Diciembre 2014
    Policy briefing

    In poor and developing nations pain remains largely uncontrolled. Africa is the least well served continent for access to analgesia.

  3. Cannabis policy reform in Europe

    • Tom Blickman
    21 Diciembre 2014
    Policy briefing

    While in the Americas cannabis policy reform is taking off, Europe seems to be lagging behind. At the level of national governments denial of the changing policy landscape and inertia to act upon calls for change reigns. At the local level, however, disenchantment with the current cannabis regime gives rise to new idea.

  4. Time for a Wake-up Call: An historical and ethnographic approach to the Regulation of Plant-based Stimulants

    • Pien Metaal, Anthony Henman
    20 Diciembre 2014
    Policy briefing

    The chemically-based frame of reference adopted by the UN Single Convention is mistaken in the culturally loaded and falsely “scientific” manner in which it was applied to different plants.

  5. Scheduling in the international drug control system

    • David Bewley-Taylor, Martin Jelsma, Christopher Hallam
    16 Junio 2014
    Policy briefing

    Scheduling is mostly prioritised in its repressive pole, though present debates are increasingly highlighting the need to modify the balance of the system in order to affirm the importance of the principle of health.

  6. dlr24-i_cover

    Cocaine: towards a self-regulation model

    • Grazia Zuffa
    07 Marzo 2014
    Policy briefing

    By taking cues from users’ self-regulation strategies, it is possible to design innovative operational models for drug services as well as drug policies, strengthening Harm Reduction as an alternative approach to the disease model.